Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT05673967 · COMPLETED
Trial details
- NCT number
- NCT05673967
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-09
- Primary completion
- 2024-09-12
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.